Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and Safety of Ustekinumab in Behcet's Disease: Results From the Prospective Phase 2 STELABEC Trial
Efficacy and Safety of Ustekinumab in Behcet's Disease: Results From the Prospective Phase 2 STELABEC Trial
2021
Jonathan London
Alexis Régent
Jérémie Dion
Lea Jilet
Marie Jachiet
Olivier Lidove
Fleur Cohen Aubart
Selim Aractingi
Sarah Guegan
Jean-Loup Pennaforte
Hendy Abdoul
Xavier Puéchal
Benjamin Terrier
Keywords:
Dermatology
Behcet's disease
Ustekinumab
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]